An Update from Our Firm about COVID-19

Abraham, Watkins, Nichols, Sorrels, Agosto, Aziz & Stogner remains fully operational and committed to serving our clients and colleagues throughout the Coronavirus (COVID-19) crisis. As we follow the CDC guidelines and practice social distancing, we remain available for phone consultations and remote meetings with both current and prospective clients and colleagues. Please contact our office by email or by calling 713-222-7211 with any questions. We look forward to hearing from you.

Posts tagged "dangerous drug"

Severity of Biologics

Biologics, a short term for biological medication, are typically prescribed to nurse autoimmune skin diseases, joints, and gastrointestinal system. They are one of the few drugs that are not made chemically, but instead are extracted from animal cells in laboratories. They are also given by either injection or IV. These drugs can cost up to more than $40,000 a year and are very established in the market. However, these biologic drugs tend to cause many severe issues to consumer's health, maybe more serious than prior to taking the drug. A list of common biologics are Remicade, Humira, Enbrel, Siliq, and Cimzia.

Lawsuit Alleges Houston Gas Stations' "Enhancement" Pills Contain Viagra and Other Pharmaceuticals

A lawsuit filed in Houston federal court in August claims that at least 15 gas stations scattered throughout the Houston area have been selling pills packaged as over-the-counter "sexual enhancement" supplements that actually contain a number of prescription drugs. Although the pills are marketed with statements like "all natural," "no harmful synthetic chemicals," and "no prescription necessary," the lawsuit alleges that independent lab testing has detected drugs including sildenafil, tadalafil, desmethyl carbodenafil, and dapoxetine-otherwise known as Viagra, Cialis, Priligy, and Westoxetin, respectively.

A New Drug for Cataract Surgery Leaves at Least 68 People Nearly Blind

A botched knockoff of the drug Tri-Moxi (which is often injected into a patient's eye during cataract surgery) has caused at least 68 people in the Dallas area to suffer partial blindness or worse within days or weeks of being injected in the eye during routine cataract surgery. The original inventors of Tri-Moxi, Imprimis, have maintained that the original formula is safe. The alleged purpose of Tri-Moxi is to prevent swelling, infection, and dryness of the operated eye.

Supplies of Top Blood Pressure Drug Tainted with Carcinogen

In late July, the U.S. Food and Drug Administration warned consumers that several pharmaceutical companies have initiated recalls of the popular blood pressure drug valsartan after discovering that the medication is contaminated with a potentially carcinogenic chemical.

Most Popular Morning Sickness Drug Zofran Presents Risks of Birth Defects

Zofran (ondansetron) is an antinausea drug originally developed to help cancer patients with the nausea and vomiting associated with chemotherapy and radiation treatments. The drug works by preventing a certain type of nerve receptor from sending signals that the brain interprets as nausea. As doctors started noticing how effective it was, they began to prescribe it to pregnant patients for morning sickness "off-label," which means that the Food and Drug Administration never approved it for that use. It became the most commonly prescribed morning-sickness treatment in America, but now hundreds of mothers are filing lawsuits against Zofran's manufacturers, claiming that it caused severe birth defects, including heart defects, cleft palates and lips, kidney malformations, skull deformities, and club foot.

Xarleto First Lawsuit Loss

Johnson & Johnson and Bayer were recently ordered by a Philadelphia court to pay $27.8 million in damages to an Indiana couple. The pharmaceutical companies failed to sufficiently warn patients of the risk of internal bleeding associated with the drug, Xarelto. This judgment marks the first lawsuit loss over Xarelto. Johnson & Johnson and Bayer have been cleared of liability in the previous three federal trails that involved the drug.

Man Commits Suicide After Taking Antidepressant

Stewart Dolin, a 57-year-old Chicago lawyer, committed suicide by throwing himself in front of an oncoming train. He had started paroxetine, the generic form of Paxil, five days before his death. His wife, Wendy Dolin, sued the original manufacturer of Paxil, GlaxoSmithKline, claiming the company failed to sufficiently warn of the risks associated with the drug.

Children's Homeopathic Ear and Teething Relief Products Recalled Due to Belladonna

Recently, the FDA posted a voluntary recall from Raritan Pharmaceuticals of homeopathic children's remedies containing belladonna extract. Belladonna, also known as "deadly nightshade," is a plant traditionally used in herbal remedies that can be poisonous, and even fatal, if consumed in a sufficiently large dose. The recall affects the following Raritan products: Kids Relief Homeopathic Ear Relief Oral Liquid, CVS Homeopathic Kids' Ear Relief Liquid, and CVS Homeopathic Infants' Teething Tablet.

Superbug Summit

Well over half a million people die every year as a result of drug resistant antimicrobials, with as many as 2 million being infected in the United States alone. Last week, a group of normally competing pharmaceutical companies came together to put together a plan for reducing drug resistance in the coming years. Some of these companies pledged to cut the environmental footprint made by antibiotic production, while others said they'd share surveillance data, improve access to antibiotics, vaccines, and diagnostics, and some pledged to look into new methods of research and development.

Reliable Drug Pharmacy Recall

The FDA has announced the voluntary recall for Reliable Drug Pharmacy compounding products due to mislabeling. Many of these products have been distributed to medical professionals, patients, and veterinarians in California, New Mexico, Hawaii, and Michigan. As a result, this group has been put on alert to check their supplies for any products labeled as Reliable Drug or Reliable Compounding Pharmacy.

  • $50+ Million Personal Injury Fire and Explosion

    The firm successfully represented nearly 100 victims who suffered personal injuries and damages to property from a large fire and explosion resulting in a settlement of more than $50 million. The firm served as lead lawyers on the steering committee in this litigation.

  • $80 Million Personal Injury Large Plant Explosion

    The firm successfully represented 270 plaintiffs, taking a lead role in the plaintiffs’ steering committee, who suffered injuries in a large plant explosion resulting in a settlement of nearly $80 million.

  • $50+ Million Personal Injury Plant Fire and Explosion

    The firm successfully represented 45 personal injury victims in a plant fire and explosion, serving on the plaintiffs steering committee, concluding with a settlement of more than $50 million.

  • $22+ Million Personal Injury Work Site Accident

    The firm prevailed in a personal injury trial for a worksite injury client with the jury returning a verdict and resulting in a judgment of over $22 million for the firm’s client.

  • $12 Million Auto Accident 18-Wheeler Collision

    The firm successfully achieved a $12 million settlement for the family of a man who died in an 18 wheeler collision.

  • $30 Million Personal Injury Burn Victims

    The firm prevailed on behalf of three burn victims with settlements totaling nearly $30 million.

Our Record Of Success

When you are hurt and you choose a law firm to represent you in court or at the negotiation table, you need to carefully consider the firm's record.

Read More Success Stories

Let Us Help You Request a Free Consultation Today

Get Help Now

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Back to top